Profiling of Bile Microbiome Identifies District Microbial Population between Choledocholithiasis and Cholangiocarcinoma Patients.
bile microbiome
cholangiocarcinoma
choledocholithiasis
genotoxin-producing E. coli
Journal
Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625
Informations de publication
Date de publication:
01 Jan 2021
01 Jan 2021
Historique:
received:
03
11
2020
entrez:
28
1
2021
pubmed:
29
1
2021
medline:
21
9
2021
Statut:
epublish
Résumé
Choledocholithiasis (CDL), a potential risk for cholangiocarcinoma (CCA) development, is often a consequence of bacterial infection. Thus, the microbial population that contributes to CDL might also be involved in CCA development. We compared the microbiome in bile fluid of CDL patients and CCA patients. Bile samples were collected from CDL (n = 30) and CCA (n =30) patients. Microbial profiling was performed individually by the sequencing of V3-V4 regions of the 16S rRNA gene. Enterobacter, Pseudomonas, and Stenotrophomonas species were much more abundant in bile samples from CCA compared to CDL (p.
Identifiants
pubmed: 33507704
doi: 10.31557/APJCP.2021.22.1.233
pmc: PMC8184169
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
233-240Références
Hepatology. 2019 Apr;69(4):1803-1815
pubmed: 30251463
PLoS Med. 2007 Jul;4(7):e201
pubmed: 17622191
J Hepatol. 2012 Jul;57(1):69-76
pubmed: 22420979
Liver Int. 2019 May;39 Suppl 1:19-31
pubmed: 30851228
Sci Transl Med. 2012 Jun 6;4(137):137rv7
pubmed: 22674557
Gastrointest Endosc. 2001 Sep;54(3):346-50
pubmed: 11522976
BMC Cancer. 2015 Nov 02;15:831
pubmed: 26526500
EBioMedicine. 2016 Jun;8:195-202
pubmed: 27428430
Gut. 2020 Apr;69(4):665-672
pubmed: 31243055
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
Parasitol Int. 2017 Aug;66(4):510-514
pubmed: 27965165
Parasitol Int. 2012 Mar;61(1):130-5
pubmed: 21704729
Investig Clin Urol. 2020 Feb;61(Suppl 1):S43-S50
pubmed: 32055753
Nat Genet. 2013 Dec;45(12):1474-8
pubmed: 24185513
Front Oncol. 2019 Aug 29;9:813
pubmed: 31555583
J Gastroenterol Hepatol. 2003 Mar;18(3):333-6
pubmed: 12603536
Gut. 2014 Dec;63(12):1932-42
pubmed: 24658599
Clin Microbiol Rev. 2015 Apr;28(2):419-42
pubmed: 25788515
Int J Cancer. 2007 Feb 1;120(3):638-41
pubmed: 17109384
World J Gastroenterol. 2004 Nov 15;10(22):3318-21
pubmed: 15484308
Immunology. 2017 Aug;151(4):363-374
pubmed: 28542929
Front Cell Infect Microbiol. 2014 Jan 07;3:115
pubmed: 24432250
Southeast Asian J Trop Med Public Health. 1988 Dec;19(4):633-6
pubmed: 3238475
Nature. 2012 May 09;486(7402):222-7
pubmed: 22699611
Appl Environ Microbiol. 2007 Aug;73(16):5261-7
pubmed: 17586664
Nat Genet. 2012 May 06;44(6):690-3
pubmed: 22561520
Toxins (Basel). 2018 Apr 10;10(4):
pubmed: 29642622
Nat Rev Genet. 2012 Mar 13;13(4):260-70
pubmed: 22411464
Gastroenterology. 2007 Feb;132(2):551-61
pubmed: 17258726
Biomed Res Int. 2019 Sep 25;2019:1092563
pubmed: 31662965
Microbiome. 2019 Jul 4;7(1):100
pubmed: 31272480
Clin Microbiol Infect. 2016 Feb;22(2):178.e11-178.e22
pubmed: 26493848
Cancer Lett. 2017 Aug 28;402:9-15
pubmed: 28527946
Science. 2006 Aug 11;313(5788):848-51
pubmed: 16902142
Anaerobe. 2017 Oct;47:70-72
pubmed: 28442420
Science. 2012 Oct 5;338(6103):120-3
pubmed: 22903521
Biol Lett. 2014 Feb 12;10(2):20131037
pubmed: 24522631
Carcinogenesis. 2002 Mar;23(3):529-36
pubmed: 11895869
PLoS One. 2017 Aug 10;12(8):e0182924
pubmed: 28796833